Fibrinolytic therapy in suspected acute myocardial infarction. 1994

R C Davis

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006342 Heart Rupture, Post-Infarction Laceration or tearing of cardiac tissues appearing after MYOCARDIAL INFARCTION. Post-Infarction Heart Rupture,Cardiac Rupture, Post-Infarction,Cardiac Rupture, Post Infarction,Cardiac Ruptures, Post-Infarction,Heart Rupture, Post Infarction,Heart Ruptures, Post-Infarction,Post Infarction Heart Rupture,Post-Infarction Cardiac Rupture,Post-Infarction Cardiac Ruptures,Post-Infarction Heart Ruptures,Rupture, Post-Infarction Cardiac,Rupture, Post-Infarction Heart,Ruptures, Post-Infarction Cardiac,Ruptures, Post-Infarction Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

R C Davis
April 1994, Lancet (London, England),
R C Davis
May 1994, Lancet (London, England),
R C Davis
April 1994, Lancet (London, England),
R C Davis
March 1997, The New England journal of medicine,
R C Davis
February 2004, Current treatment options in cardiovascular medicine,
R C Davis
February 1987, Revista medica de Chile,
R C Davis
February 1972, The New England journal of medicine,
R C Davis
December 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology,
Copied contents to your clipboard!